| 论文标题 | 作者 | 发表时间 | 发表杂志 | 影响因子 |
|---|---|---|---|---|
| Prediction of Clinical Bronchiectasis from Asymptomatic Radiological Bronchiectasis | Yamin Fan, Zhuanyun Li, Nanchuan Jiang, Yaya Zhou, Jianping Song, Fan Yu, Jianchu Zhang, Xiaorong Wang |
2025-04 |
Journal of inflammation research |
4.2 |
| Lactate dehydrogenase to albumin ratio and prognosis in patients with acute exacerbation of chronic obstructive pulmonary disease: a retrospective cohort study | Chao-Wei Ding, Shen-Shen Huang, Yan-Hong Xu, Xu Chu, Lan Wang, Yi-Min Mao, Ya-Dong Yuan, Jia-Yong Qiu. |
2025-04 |
BMC pulmonary medicine |
2.6 |
| Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC) | Jennifer Pollock, Eva Polverino, Raja Dhar, Katerina Dimakou, Letizia Traversi, Apostolos Bossios, Charles Haworth, Michael R Loebinger, Anthony De Soyza, Montserrat Vendrell, Pierre Regis Burgel, Pontus Mertsch, Melissa Jane McDonnell, Sabina Skgrat, Luis Maiz-Carro, Oriol Sibila, Menno van der Eerden, Paula Kauppi, Adam T Hill, Robert Wilson, Branislava Milenkovic, Rosario Menéndez, Marlene Murris, Megan L Crichton, Sermin Borecki, Dusanka Obradovic, Muhammed Irfan, Venera Eshenkulova, Adam Nowinski, Adelina Amorim, Antoni Torres, Natalie Lorent, Tobias Welte, Francesco Blasi, Eva Van Braeckel, Josje Altenburg, Michal Shteinberg, Wim Boersma, Joseph Stuart Elborn, Stefano Aliberti, Felix C Ringshausen, Pieter Goeminne, James D Chalmers. |
2025-03 |
Thorax |
9 |
| Effective compound combination of Bufei Yishen formula ameliorates PM2.5-induced COPD by inhibiting mitochondrial oxidative stress through SIRT3-mediated FOXO3 deacetylation | Jing Wang, Huiyu Yue, Yangzi Dong, Tiantian Liu, Jiansheng Li. |
2025-03 |
Phytomedicine |
6.7 |
| Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months | Charles S Haworth, Michal Shteinberg, Kevin Winthrop, Alan Barker, Francesco Blasi, Katerina Dimakou, Lucy C Morgan, Anne E O'Donnell, Felix C Ringshausen, Oriol Sibila, Rachel M Thomson, Kevin J Carroll, Federica Pontenani, Paola Castellani, James D Chalmers. |
2024-09 |
The Lancet. Respiratory medicine |
38.7 |
| COPD is associated with increased cardiovascular disease risk independent of phenotype | Cobb K, Kenyon J, Lu J, Krieger B, Perelas A, Nana-Sinkam P, Kim Y, Rodriguez-Miguelez P. |
2024-07 |
Respirology |
6.6 |
| The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007-2012. | Cadham CJ, Oh H, Han MK, Mannino D, Cook S, Meza R, Levy DT, Sánchez-Romero LM. |
2024-05 |
Respiratory research |
4.7 |
| Lipomatous hypertrophy of the interatrial septum: a distinct adipose tissue type in COPD? | Lacaita PG, Kindl B, Plank F, Beyer C, Bilgeri V, Barbieri F, Senoner T, Dichtl W, Tancevski I, Swoboda M, Luger A, Deeg J, Widmann G, Feuchtner GM. |
2024-09 |
ERJ open research |
4.3 |
| Autologous transplantation of P63+lung progenitor cells for chronic obstructive pulmonary disease therapy | Wang Y, Meng Z, Liu M, Zhou Y, Chen D, Zhao Y, Zhang T, Zhong N, Dai X, Li S, Zuo W. |
2024-02 |
Science translational medicine |
15.8 |
| The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study | Chen S, Kuhn M, Prettner K, Yu F, Yang T, Bärnighausen T, Bloom DE, Wang C. |
2023-08 |
The Lancet. Global health |
19.9 |
